| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 48 |
| 1 | METHYLPREDNISOLONE | 5 |
| 2 | PANTOPRAZOLE | 5 |
| 3 | ALPRAZOLAM | 4 |
| 4 | FOLIC ACID | 4 |
| 5 | IBUPFROFEN | 4 |
| 6 | IBUPROFEN | 4 |
| 7 | IBUPROFEN 200 MG | 4 |
| 8 | IBUPROFEN 200MG | 4 |
| 9 | IBUPROFEN CAPSULE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DANICOPAN | 1 | 0.0032 |
| 1 | MITAPIVAT | 4 | 0.0030 |
| 2 | IPTACOPAN | 1 | 0.0013 |
| 3 | CAPLACIZUMAB | 2 | 0.0011 |
| 4 | ECULIZUMAB | 48 | 0.0009 |
| 5 | SODIUM CITRATE | 1 | 0.0008 |
| 6 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 7 | PEGCETACOPLAN | 1 | 0.0005 |
| 8 | ALBUMIN HUMAN | 2 | 0.0004 |
| 9 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 49 |
| 1 | Corticosteroid [EPC] | 15 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 3 | Azole Antifungal [EPC] | 6 |
| 4 | Benzodiazepine [EPC] | 6 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 6 | Pyruvate Kinase Activator [EPC] | 4 |
| 7 | Vitamin B12 [EPC] | 4 |
| 8 | Vitamin C [EPC] | 4 |
| 9 | Vitamin D [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 1 | Pyruvate Kinase Activator [EPC] | 4 | 0.0030 |
| 2 | Complement Inhibitor [EPC] | 49 | 0.0009 |
| 3 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 9 | Anticholinergic [EPC] | 1 | 0.0001 |